[HTML][HTML] Manipulating TGF-β signaling to optimize immunotherapy for cervical cancer
S Yin, H Cui, S Qin, S Yu - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Cervical cancer is a serious threat to women's health globally. Therefore, identifying key
molecules associated with cervical cancer progression is essential for drug development …
molecules associated with cervical cancer progression is essential for drug development …
[HTML][HTML] Modern tools for modern brachytherapy
D Berger, S Van Dyk, L Beaulieu, T Major, T Kron - Clinical Oncology, 2023 - Elsevier
This review aims to showcase the brachytherapy tools and technologies that have emerged
during the last 10 years. Soft-tissue contrast using magnetic resonance and ultrasound …
during the last 10 years. Soft-tissue contrast using magnetic resonance and ultrasound …
Mitochondria-targeted NO donor enables synergistic NO and photodynamic therapies for effective inhibition of cancer cell proliferation and migration
Y Jiang, S Huang, M Liu, J Weng, W You, X Du… - Dyes and …, 2024 - Elsevier
Previously reported light-controlled nitric oxide donors are usually activated by blue or green
light. The insufficient ability of short wavelength light to penetrate tissues and its potential …
light. The insufficient ability of short wavelength light to penetrate tissues and its potential …
Single‐Nucleus Transcriptome Profiling of Locally Advanced Cervical Squamous Cell Cancer Identifies Neural‐Like Progenitor Program Associated with the Efficacy …
L Zhang, J Ma, D Zhou, J Zhou, B Hu, X Ma… - Advanced …, 2023 - Wiley Online Library
Radiotherapy is the first‐line treatment for locally advanced cervical squamous cell cancer
(CSCC). However,≈ 50% of patients fail to respond to therapy and, in some cases, tumors …
(CSCC). However,≈ 50% of patients fail to respond to therapy and, in some cases, tumors …
Systematic pan-cancer analysis identifies SLC31A1 as a biomarker in multiple tumor types
Abstract Background Solute Carrier Family 31 Member 1 (SLC31A1) has recently been
identified as a cuproptosis-regulatory gene. Recent studies have indicated that SLC31A1 …
identified as a cuproptosis-regulatory gene. Recent studies have indicated that SLC31A1 …
Combining Radiotherapy with Immunotherapy in Cervical Cancer: Where Do We Stand and Where Are We Going?
Y Peng, H Yan, W Mei, P Zhang, C Zeng - Current Treatment Options in …, 2023 - Springer
Opinion statement Combining immunotherapy and radiotherapy as a treatment strategy for
cervical cancer has attracted increasing attention. The primary objective of this review is to …
cervical cancer has attracted increasing attention. The primary objective of this review is to …
Circular RNAs and cervical cancer: friends or foes? A landscape on circRNA-mediated regulation of key signaling pathways involved in the onset and progression of …
E Heydarnia, Z Dorostgou, N Hedayati… - Cell Communication and …, 2024 - Springer
Cervical cancer (CC) is a common gynecologic malignancy, accounting for a significant
proportion of women death worldwide. Human papillomavirus (HPV) infection is one of the …
proportion of women death worldwide. Human papillomavirus (HPV) infection is one of the …
Bacteria-targeted delivery of black phosphorus quantum dots facilitates photothermal therapy against hypoxic tumors and complementary low-dose radiotherapy
P Ji, J Chen, H Wang, L Shi, X Tang, Y Duo - Biomaterials Science, 2023 - pubs.rsc.org
Many approaches have been employed to relieve hypoxia in solid tumors to enhance
sensitivity to radiotherapy (RT), including O2 delivery or hydrogen peroxide (H2O2) …
sensitivity to radiotherapy (RT), including O2 delivery or hydrogen peroxide (H2O2) …
Completion surgery after intensity-modulated arc therapy for locally advanced cervical cancer: long-term follow-up and update on surgical outcome and oncologic …
A Van Damme, J Rombaut, A Makar… - World Journal of …, 2023 - Springer
Background Chemoradiotherapy (CRT) followed by brachytherapy (BT) is the standard
treatment for locally advanced cervical cancer (LACC), but replacement of BT by surgery …
treatment for locally advanced cervical cancer (LACC), but replacement of BT by surgery …
Cervical cancer segmentation based on medical images: a literature review
X Wang, C Feng, M Huang, S Liu… - Quantitative Imaging in …, 2024 - pmc.ncbi.nlm.nih.gov
Background and Objective Cervical cancer clinical target volume (CTV) outlining and organs
at risk segmentation are crucial steps in the diagnosis and treatment of cervical cancer …
at risk segmentation are crucial steps in the diagnosis and treatment of cervical cancer …